Tirzepatide with 99% purity GLP-1 API Powder Bulk Wholesale Raw Material

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

This medication is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels.

Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.

Q1: May I get one sample before placing order?

Re: Yes, Sample are available. For normal products, samples are for free and you just need to bear the freight; For those high value products, you just need to freight and certain product cost. When we both cooperate for some times or when you are our VIP customer, free sample will be offered when you need.

Q2: Which payment is available for your company?

Re: T/T, PayPal,bank transfer etc. You can choose the one which is convenient for you.

Q3: How and when can I get my goods after payment?

Re: For small quantity products, they will be delivered to you by international courier(DHL, FedEx, TNT etc.) or by air. Usually it will cost 5-7days that you can get the goods after delivery.For large quantity products, shipping by see is worthwhile.It will cost 15 to 30 days to come to your destination port, which depends on where the port is.

Q4: Is there any possible to use my appointed label or package?

Re: Yes. If needed, we'd like  to do that.

Hangzhou Thinheal Pharma-Tech Co., Ltd. was established in 2019. It is a biopharmaceutical company that combines independent R&D, production, sales and customized research and development and production of peptide products. The core management team is composed of professionals with a pharmaceutical background and nearly 20 years of management experience in the peptide industry. Thinheal has built a R&D center and a production base. The total production capacity of chemically synthesized peptides has now reached several tons, ranking at the forefront of the industry.

The company has a complete and efficient peptide R&D, production and sales system, and provides a full range of peptide industrialization services, including peptide API R&D and production business, peptide customized R&D and production (CDMO) business, and beauty peptide research and development and production business. The company's revenue is mainly from peptide API business. Peptide API products mainly include more than 20 varieties such as semaglutide, tirzepatide, liraglutide, etc., among which semaglutide, tirzepatide and other varieties have completed the US FDA DMF filing. The CDMO business includes project-based entrusted research and development, entrusted production and sales. The main customers of the CDMO business are innovative drug companies and scientific research institutions, among which some pharmaceutical companies have cooperated with Thinheal since the product development stage and have established a solid cooperative relationship.